Hartley Lindsey Marie 4
4 · Axogen, Inc. · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Transactions
- Exercise/Conversion
Common Stock
2025-12-08$15.22/sh+20,000$304,400→ 40,763 total - Exercise/Conversion
Common Stock
2025-12-08$8.20/sh+5,000$41,000→ 45,763 total - Sale
Common Stock
2025-12-08$31.56/sh−11,533$363,935→ 34,230 total - Sale
Common Stock
2025-12-08$31.56/sh−2,854$90,069→ 31,376 total - Exercise/Conversion
Employee Stock Option (right to purchase)
2025-12-08−20,000→ 0 totalExercise: $15.22Exp: 2031-11-01→ Common Stock (20,000 underlying) - Exercise/Conversion
Employee Stock Option (right to purchase)
2025-12-08−5,000→ 2,500 totalExercise: $8.20Exp: 2032-03-16→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested on November 1, 2025 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on November 1, 2023 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.
- [F2]All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the option grant date) and an additional 12.5% of the aggregate shares have vested or will vest each 6 months thereafter.